Sonoma Pharmaceuticals Inc. logo

Sonoma Pharmaceuticals Inc.

SNOA | NASDAQ
Chart Builder DCF Calculator
$1.25
-$0.03 (-2.34%)
At close: Sep 21, 2026, 4:00 PM ET
$1.27
+$0.02 (+1.49%)
Pre-market: Sep 22, 2026, 7:00 AM ET

Market Data

Market Cap
$2.16M
Enterprise Value
$-2.49M
Beta
1.31
Average Volume
148.61K
Shares Outstanding (Diluted)
3.85M
Shares Change YoY
134.37%
Institutional Ownership
4.01%
Exchange
NASDAQ
ISIN
US83558L3033

Price Performance

Price Change 1M
-5.3%
Price Change 3M
9.7%
Price Change 6M
-45.2%
Price Change YTD
-65.7%
Price Change 1Y
-70.0%
Price Change 3Y
-92.0%
Price Change 5Y
-98.8%
1M CAGR (ann.)
2.4%
1Y CAGR (ann.)
-68.6%
5Y CAGR (ann.)
-59.1%
All-Time CAGR
-41.5%

Valuation

PE Ratio
-1.02
Forward PE
N/A
PEG Ratio
-0.01
Forward PEG
0.01
PS Ratio
0.10
Forward PS
0.10
PB Ratio
0.32
P/FCF Ratio
-0.98
P/Adj. FCF Ratio
-0.87
P/OCF Ratio
-2.36
EV/Sales
-0.11
EV/EBIT
1.47
EV/EBITDA
1.57
EV/FCF
1.16
Earnings Yield
-97.6%
FCF Yield
-102.2%
Adj. FCF Yield
-114.4%

Financial Health

Net Cash
$4.6M
Total Debt
$739K
Cash & Short-Term Investments
$5.34M
Total Assets
$18.11M
Current Ratio
2.99
Quick Ratio
2.29
Debt / Equity Ratio
0.11
Debt / EBITDA
-0.46
Debt / FCF
-0.34
OCF / Debt
-2.74
Interest Coverage
0.00
Altman Z-Score
-13.83
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
38.9%
Operating Profit Margin
-6.4%
EBITDA Margin
-7.3%
Net Profit Margin
-10.3%
FCF Margin
-9.8%
Adj. FCF Margin
-11.0%
SBC / Revenue
1.2%
SBC Impact (per share)
-11.9%

Returns

Return on Assets
-12.5%
Return on Equity
-53.6%
Return on Invested Capital
-9.8%
Return on Capital Employed
-11.1%
Return on Tangible Assets
-12.5%

Historical Growth (CAGR)

Revenue CAGR 3Y
19.9%
Revenue CAGR 5Y
5.8%
Revenue CAGR 10Y
5.6%
EPS CAGR 3Y
81.1%
EPS CAGR 5Y
51.1%
EPS CAGR 10Y
38.7%
FCF CAGR 3Y
-24.1%
FCF CAGR 5Y
33.2%
FCF CAGR 10Y
20.5%

Analyst Forecasts

Analyst Rating
Hold
Analyst Count
0
EPS Growth Next 3Y
N/A
Revenue Growth Next 3Y
N/A
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Cash Flow

Operating Cash Flow
$-2.03M
Free Cash Flow
$-2.15M
Adj. Free Cash Flow
$-2.41M
FCF Per Share
-$0.56
OCF Per Share
-$0.53
OCF/S Ratio
-9.2%

Income Statement

Revenue
$21.92M
Gross Profit
$8.53M
Operating Income
$-1.41M
EBITDA
$-1.59M
Net Income
$-2.26M
EPS (Diluted)
-$1.22
Revenue / Employee
$2.19M
Profit / Employee
$-226.4K
Employees
10

© 2026 bestshares.com. All rights reserved.